Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY.
The item "Diluted-EPS" stands at 19.98 Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2020.
Takeda Pharmaceutical Co. Ltd.'s second quarter result of -7.48 JPY for the item "Diluted EPS" represents a decrease of -109.56 percent compared to it's first quarter result.
Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of -7.48 JPY for the item "Diluted EPS" represents a decrease of -113.09 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 19.98 JPY for the item "Diluted EPS" represents a decrease of -76.40 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -161.91 Japanese Yens compared to the value the year prior.
The 1 year change is -161.91 Japanese Yens.
The 3 year change is -116.41 Japanese Yens.
The 5 year change is -42.34 Japanese Yens.
The 10 year change is 117.41 Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted EPS | 905,699,262,464.00 |
![]() | Johnson & Johnson - Diluted EPS | 486,508,953,600.00 |
![]() | AbbVie Inc - Diluted EPS | 399,570,305,024.00 |
![]() | Roche Holding AG - Diluted EPS | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted EPS | 280,205,508,085.11 |